118 related articles for article (PubMed ID: 19907439)
1. A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma.
Chanudet E; Huang Y; Ichimura K; Dong G; Hamoudi RA; Radford J; Wotherspoon AC; Isaacson PG; Ferry J; Du MQ
Leukemia; 2010 Feb; 24(2):483-7. PubMed ID: 19907439
[No Abstract] [Full Text] [Related]
2. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.
Chanudet E; Ye H; Ferry J; Bacon CM; Adam P; Müller-Hermelink HK; Radford J; Pileri SA; Ichimura K; Collins VP; Hamoudi RA; Nicholson AG; Wotherspoon AC; Isaacson PG; Du MQ
J Pathol; 2009 Feb; 217(3):420-30. PubMed ID: 19006194
[TBL] [Abstract][Full Text] [Related]
3. TNFAIP3 abnormalities in MALT lymphoma with autoimmunity.
Chanudet E; Huang Y; Zeng N; Streubel B; Chott A; Raderer M; Du MQ
Br J Haematol; 2011 Aug; 154(4):535-9. PubMed ID: 21518331
[No Abstract] [Full Text] [Related]
4. A20 inactivation in ocular adnexal MALT lymphoma.
Bi Y; Zeng N; Chanudet E; Huang Y; Hamoudi RA; Liu H; Dong G; Watkins AJ; Ley SC; Zou L; Chen R; Zhu X; Du MQ
Haematologica; 2012 Jun; 97(6):926-30. PubMed ID: 22207688
[TBL] [Abstract][Full Text] [Related]
5. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.
Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M
Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247
[TBL] [Abstract][Full Text] [Related]
6. Thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a clinicopathological and genetic analysis of six cases.
Go H; Cho HJ; Paik JH; Park CM; Oh YH; Jung KC; Kim CW; Jeon YK
Leuk Lymphoma; 2011 Dec; 52(12):2276-83. PubMed ID: 21745165
[TBL] [Abstract][Full Text] [Related]
7. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
[TBL] [Abstract][Full Text] [Related]
8. [Significance of A20 in B-cell lymphomas].
Kato M; Ogawa S
Rinsho Ketsueki; 2011 Apr; 52(4):190-7. PubMed ID: 21566404
[No Abstract] [Full Text] [Related]
9. Frequent inactivation of A20 through gene mutation in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Akatsuka M; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Rinsho Ketsueki; 2011 Jun; 52(6):313-9. PubMed ID: 21737982
[No Abstract] [Full Text] [Related]
10. Mutation analysis of NF-κB signal pathway-related genes in ocular MALT lymphoma.
Liu F; Karube K; Kato H; Arita K; Yoshida N; Yamamoto K; Tsuzuki S; Kim W; Ko YH; Seto M
Int J Clin Exp Pathol; 2012; 5(5):436-41. PubMed ID: 22808296
[TBL] [Abstract][Full Text] [Related]
11. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
[TBL] [Abstract][Full Text] [Related]
12. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.
Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507
[TBL] [Abstract][Full Text] [Related]
13. Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.
Parry M; Rose-Zerilli MJ; Ljungström V; Gibson J; Wang J; Walewska R; Parker H; Parker A; Davis Z; Gardiner A; McIver-Brown N; Kalpadakis C; Xochelli A; Anagnostopoulos A; Fazi C; de Castro DG; Dearden C; Pratt G; Rosenquist R; Ashton-Key M; Forconi F; Collins A; Ghia P; Matutes E; Pangalis G; Stamatopoulos K; Oscier D; Strefford JC
Clin Cancer Res; 2015 Sep; 21(18):4174-4183. PubMed ID: 25779943
[TBL] [Abstract][Full Text] [Related]
14. A20 overexpression under control of mouse osteocalcin promoter in MC3T3-E1 cells inhibited tumor necrosis factor-alpha-induced apoptosis.
Qin YJ; Zhang ZL; Yu LY; He JW; Hou YN; Liu TJ; Wu JC; Wu SH; Guo LH
Acta Pharmacol Sin; 2006 Sep; 27(9):1231-7. PubMed ID: 16923345
[TBL] [Abstract][Full Text] [Related]
15. Aberrant promoter methylation in gastric lymphoma.
Fung MK; Au WY; Liang R; Srivastava G; Kwong YL
Haematologica; 2003 Feb; 88(2):231-2. PubMed ID: 12604419
[No Abstract] [Full Text] [Related]
16. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.
Arribas AJ; Rinaldi A; Mensah AA; Kwee I; Cascione L; Robles EF; Martinez-Climent JA; Oscier D; Arcaini L; Baldini L; Marasca R; Thieblemont C; Briere J; Forconi F; Zamò A; Bonifacio M; Mollejo M; Facchetti F; Dirnhofer S; Ponzoni M; Bhagat G; Piris MA; Gaidano G; Zucca E; Rossi D; Bertoni F
Blood; 2015 Mar; 125(12):1922-31. PubMed ID: 25612624
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of A20 prevents cardiac cell death and myocardial dysfunction after myocardial infarction.
Shaw J; Eydelnant IA; Kirshenbaum LA
Circulation; 2007 Apr; 115(14):1827-9. PubMed ID: 17420361
[No Abstract] [Full Text] [Related]
20. [Study of methylation of promoter of EYA1 gene in microtia].
Lin L; Pan B; Jiang HY; Zhuang HX; Zhao YY; Yang QH; He LR; Han J; Wang SJ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2009 Nov; 25(6):436-9. PubMed ID: 20209935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
